VenomAid Diagnostics ApS: Financial statements 2025
CVR: 39981165
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
VenomAid Diagnostics ApS (CVR 39981165) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -867,480 and a net result of DKK -3,853,829 compared with DKK -3,694,270 the year before. Equity in the 2025 report amounted to DKK -11,289,971. The company had 5 employees in the financial year.
- Gross Profit
- DKK -867,480
- Profit/Loss
- DKK -3,853,829
- Equity
- DKK -11,289,971
- Total Assets
- DKK 5,131,064
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -867 t. | -3.9 mio. | -11.3 mio. | 5 |
| 2024 | - | -603 t. | -3.7 mio. | -7.4 mio. | 5 |
| 2023 | - | 154 t. | -2.9 mio. | -3.7 mio. | 5 |
| 2022 | - | 304 t. | -915 t. | -821 t. | 3 |
| 2021 | 90 t. | 8 t. | -24 t. | 94 t. | - |
Official annual report
How creditworthy is VenomAid Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 29, 2025, LAUSTSEN VENTURES ApS is registered as an owner of VenomAid Diagnostics ApS with an ownership share of 20%.
As of September 29, 2025, Moleculo Holdings ApS is registered as an owner of VenomAid Diagnostics ApS with an ownership share of 33%.
As of September 29, 2025, Sirius Ventures ApS is registered as an owner of VenomAid Diagnostics ApS with an ownership share of 10%.
VenomAid Diagnostics ApS has published its annual report for 2024. Gross profit came to DKK -603,402, and the net result was DKK -3,694,270.
About VenomAid Diagnostics ApS
VenomAid Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jonas Arnold Jürgensen-Breum. The board consists of Gert Fisker Tomczyk (chair), Andreas Hougaard Laustsen-Kiel, Mads Aage Laustsen and Morten Boje Munk. The company's owners include LAUSTSEN VENTURES ApS, Moleculo Holdings ApS and Ubia Holdings ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -867,480 and a net result of DKK -3,853,829 compared with DKK -3,694,270 the year before. Equity in the 2025 report amounted to DKK -11,289,971.